Analytical problems in determination of hemoglobin A 1c and the different ways of its interpretation;A hemoglobin-A 1c -meghatározás analitikai problémái és az eredményközlé s gondjai

Orvosi Hetilap

Volumn 150, Issue 16, 2009, Pages 747-751

  Góth, László ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Pf 55   (Hungary)

Author keywords

EADAG; Hemoglobin A1c; Interferences; Methods; Standardization

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN;

ARTICLE; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; STANDARDIZATION; BLOOD; BLOOD ANALYSIS; METABOLISM; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; STANDARD;

BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS;

EID: 66649125886     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2009.28603     Document Type: Article

References (24)

1. Allen, D. W., Shroeder, W. A., Balog J.: Observations on the chro-matographic heterogeneity of normal adult and fetal human hemoglobin: a study of the effects of crystallization and chroma-tography on the heterogeneity and isoleucine content. J. Am. Chem. Soc., 1958, 80, 1628-1634.
2. Trivelli, L. A., Ranney, H. M., Lai, H. T.: Hemoglobin components in patients with diabetes mellitus. N. Engl. J. Med., 1971, 284, 353-357.
3. Koenig, R. J., Peterson, C. M., Kilo, C. és mtsai: Hemoglobin Alc as an indicator of the degree of glucose intolerance in diabetes. Diabetes, 1976, 25, 230-232.
4. Goldstein, D. E., Parker, K. M., England, K. és mtsai: Clinical application of hemoglobin measurements. Diabetes, 1982, 31, 70-82.
5. Nathan, D. M., Singer, D. E., Hurxtal, K. és mtsa: The clinical information value of glycosylated hemoglobin assay. N. Engl. J. Med., 1984, 310, 341-346.
6. Peterson, K. P., Pavlovich, J. G., Goldstein, D. és mtsai: What is hemoglobin A1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry. Clin. Chem., 1998, 44, 1951-1958.
7. The DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med., 1993, 329, 1608-1617.
8. UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998, 352, 857-863.
9. American Diabetes Association: Clinical practice recommendations 1999. Diabetes Care, 1999, 22(Supl 1), S1-S114.
10. Sacks, D. B.: Carbohydrates. In Tietz Fundamentals of Clinical Chemistry. Burtis, C. A., Ashwood, E. R., Bruns, D. E. (Eds.) Saunders Elsevier, St. Louis, 2008, 378-395.
11. Sacks, D. B.: Carbohydrates. In Tietz fundamentals in clinical chemistry. (Eds.) Burtis, C. A., Ashwood, E. R. W. B. Saunders Company, St. Louis, 2001, 453.
12. Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. New Engl. J. Med., 1993, 329, 978-986.
13. NGSP. http.//www.ngsp.org
14. 1c". Clin. Chem. Lab. Med., 2007, 45, 1081-1082.
15. 1c measurement: Consensus Committee of American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical chemistry and Laboratory Medicine, International Diabetes Federation. Clin. Chem., 2007, 53, 1562-1563.
16. Bell, J. R.: The new glycohemoglobin standard. Clin. Lab. News, 2008, 34, 2-4.
17. 1c Measurement. The American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care, 2007, 30, 2339-2400.
18. The Diabetes Control and Complications Trial Research Group: Diabetes Control and Complications Trial (DCCT). Results of feasibility study. Diabetes Care, 1987, 10, 1-19.
19. 1c in the Diabetes Control and Complications Trial. Diabetes Care, 2002, 25, 275-278.
20. Kilpatrick, E. S., Rigby, A. S., Atkin, L. S.: Variability in the relationship between Mean Plasma Glucose and HbA1c: Implications for the assessment of glycemic control. Clin. Chem., 2007, 53 897-901.
21. 1c assay into estimated average glucose values. Diabetes Care, 2008, 31, 1473-1478.
22. 1c into average blood glucose: implications for clinical chemistry. Clin. Chem., 2008, 54, 1756-1758.
23. 1c-derived average glucose (ADAG) study. Clin. Chem. Lab. Med., 2008, 46, 1617-1623.
24. Mazze, R.: The future of self-monitored blood glucose: mean blood glucose versus glycosilated hemoglobin. Diabetes Technol. Ther., 2008, 10(S1), S93-S101.